A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.

Abroad (travel likely)RecruitingPHASE3

Conditions

Chikungunya Virus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • ARK Clinical Research, LLC, Fountain Valley, California, United States

    Contact: Study coordinator (Angel Galvez) · agalvez@arkclinicalresearch.com · 562-997-1000
    Contact: Principal Investigator (Justin Yanuck)
  • Emerson Clinical Research Institute- DC, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Andres Jimenez) · andres@ecrinstitute.com · 202-239-0777
    Contact: Principal Investigator (Julie Pineda, MD)
  • Acevedo Clinical Research, Miami, Florida, United States

    Contact: Study coordinator (Jonathan Castano) · j.castano@acevedoclinicalresearch.com · 305-649-8871
    Contact: Principal Investigator (Giselle Deiros, MD)
  • Hope Research Network, Miami, Florida, United States

    Contact: Study coordinator (Jose Rafael Gonzalez) · jgonzalez@hoperesearchnetwork.com · 786-953-8858
    Contact: Principal Investigator (Mario Reyes, MD)
  • Velocity Clinical Research-Omaha, Omaha, Nebraska, United States

    Contact: Study coordinator (Nathaniel Frazier) · nfrazier@velocityclinical.com · 402-933-6500
    Contact: Principal Investigator (Frederick Raiser, DO)
  • Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States

    Contact: Study coordinator (Julie Kulhanek) · Julie.Kulhanek@cchmc.org · 513-803-2109
    Contact: Principal Investigator (Robert Frenck, MD)
  • KidCare Pediatrics, Beaumont, Texas, United States

    Contact: Study coordinator (Alea White) · awhite@tektonresearch.com · 409-234-1678
    Contact: Principal Investigator (Robert Codey Bell, MD)
  • Velocity Clinical Research - Salt Lake City, West Jordan, Utah, United States

    Contact: Study coordinator (Caitlan Peterson) · cpeterson@velocityclinical.com · 801-542-8190
    Contact: Principal Investigator (Barbara Rizzardi, MD)
  • CARE CT Group Inc., Dasmariñas, Cavite, Philippines

    Contact: Study coordinator (Andre L Agoncillo) · miguelmaralitmd@yahoo.com
    Contact: Principal Investigator (Delia C Yu, MD)
  • HIMC Research and Development on Medical Sciences, Imus, Cavite, Philippines

    Contact: Study coordinator (Maria Papa) · healthindexmsc@yahoo.com
    Contact: Principal Investigator (Edison Alberto, MD)
  • Silang Specialist Medical Center, Silang, Cavite, Philippines

    Contact: Study coordinator (Y'von L Millora) · ssmcresearch@smail.com
    Contact: Principal Investigator (Maria T Gler, MD)
  • University of Perpetual Help DALTA Medical Center, Biomedical Research Institute, Las Piñas, National Capital Region, Philippines

    Contact: Study coordinator (Maria L Magboo-Gaviola) · cor_uphs@yahoo.com.ph
    Contact: Principal Investigator (Mitzi C Trinidad-Aseron, MD)
  • Institute of Child Health and Human Development, University of the Philippines, Manila, National Capital Region, Philippines

    Contact: Study coordinator (Michael Tee) · oc@upm.edu.ph
    Contact: Principal Investigator (Michelle C Ylade, MD)
  • University of the Philippines-Philippine General Hospital, Manila, Philippines

    Contact: Study coordinator (Michael L Tee) · oc@upm.edu.ph
    Contact: Principal Investigator (Maria E Uy, MD)
  • CMRC Headlands LLC, San Juan, Puerto Rico, Puerto Rico

    Contact: Study coordinator (Carmen Navarro) · cnavarro@cmrcenter.com · 787-679-3324
    Contact: Principal Investigator (Carmen Deseda, MD)
Study leads
  • Patrick Ajiboye, MD

    Study Director

    Bavarian Nordic A/S